Activins exert their effects by inducing heteromeric complexes of either of two different type I receptors, ActR-I or ActR-IB, and either of two type II receptors, ActR-II or ActR-IIB. We describe the cDNA cloning of the mouse homologue of human ActR-IB and analyze binding of radio-iodinated activin on type I/type II combinations of mouse receptors expressed from cDNA. We studied the distribution of ActR-I and ActR-IB mRNAs in postimplantation mouse embryos by in situ hybridization. In the 125day postcoitum embryo, both mRNAs are found in the brain, spinal cord, some ganglia, vibrissae, lungs, body wall, stomach, gonads, ribs, limbs and shoulders. ActR-I mRNA, but not ActR-IB, is expressed in blood vessels, the heart, tongue, intervertebral discs and diaphragm. Conversely, only ActR-IB n-RNA is detected in the olfactory region, eye, tooth primordium, esophagus, mesonephros, dorsal root ganglia and is strongly expressed in the spinal cord. Our results demonstrate similarities, but also differences and complementarities (mesenchymal versus epithelial expression) between the expression patterns of these type I receptors. Moreover, their expression patterns overlap with at least one of the type II activin receptors and/or one of activin subunits in some regions of the embryo, such as the brain, spinal cord, pituitary, whisker follicles, and the inner nuclear neuroblastic layer of the eye.
Introduction
Transforming growth factor (TGF)-/3s, activins, inhibins and bone morphogenetic proteins (BMPs) are members of a large family of structurally related but functionally diverse polypeptide factors (Roberts and Sporn, 1990; Massague et al., 1994) . Activin A, B and AB (Ling et al., 1986; Vale et al., 1986 ) are believed to be multifunctional proteins in the adult and in the embryo. Originally defined as stimulators of the production and release of follicle stimulating hormone from pituitary gonadotrophs, they were later shown to be involved in many biological processes. Activins induce differentiation of * Corresponding author, Tel.: +32 16 345916; Fax: +32 16 345933 erythroleukemia cells (Murata et al., 1988; Huylebroeck et al., 1990; Shiozaki et al., 1992) , regulate the growth and differentiation of embryonal carcinoma cells (Hashimoto et al., 1990; Schubert and Kimura, 1991; van den Eijnden-van Raaij et al., 1991) and induce the formation of mesodermal cell types in animal cap explants from the amphibian embryo (Asashima et al., 1990; Green and Smith, 1990; Smith et al., 1990; Thomsen et al., 1990; van den Eijnden-van Raaij et al., 1990; Nakamura et al., 1992) . Subsequent experiments suggest that activins may act as endogenous inducers or regulators of mesoderm formation in other species, such as the chick ) and zebrafish (Schulte-Merker et al., 1992) . Injection of high amounts of mRNA encoding a truncated form of the Xenopus ac-tivin type II receptor XARl into Xenapus embryos inhibits mesoderm formation and, as does overexpression of follistatin, promotes neuralization (Hemmati-Brivanlou and Melton, 1992; . This suggests a role for this receptor in mesoderm formation, but provides no direct evidence for activins in mesoderm induction. Indeed, their proposed role in the formation of mesoderm in the early embryo is not always compatible with the onset of their mRNA expression in the embryo Stern, 1992) . Moreover, mice homozygous for null activin A and B mutations do not show any defect in mesoderm formation (Matzuk et al., 1995b) . Other members of the TGF-/3 superfamily have recently been proposed as candidate inducers or regulators of mesoderm formation (Slack, 1994) .
TGF-/% and activins exert their effects through binding to specific serine/threonine kinase receptors (Kingsley, 1994; Massague et al., 1994; Mathews, 1994; ten Dijke et al., 1994a) . Two different size classes of receptors, i.e. type I (about 53 kDa) and type II (about 70 kDa), have been shown to be important for signaling by type I/II heteromeric complexes . Using a polymerase chain reaction (PCR)-based strategy and a low stringency hybridization protocol, new receptor cDNAs, denoted activin receptor-like kinases (ALK-)-1 to -6, were obtained (Franztn et al., 1993; ten Dijke et al., 1993 ten Dijke et al., , 1994a . ALK-1 to -5 were obtained from human cells, and ALK-6 was isolated from the mouse. Recent data revealed that ALKs serve as type I receptors, i.e. ALK-5 is a functional TGF-@ type I receptor (TPR-I) (Franzen et al., 1993; Bassing et al., 1994; ten Dijke et al., 1994a) , ALK-2 (Attisano et al., 1993; Tsuchida et al., 1993; ten Dijke et al., 1994b) and ALK-4 (Carcamo et al., 1994; ten Dijke et al., 1994b) are functional activin type I receptors. We have recently shown that ALK-3 and ALK-6 bind BMP4 and osteogenic protein (OP)-1 (ten Dijke et al., 1994~) . ActR-I (ALK-2) can also bind OP-1 but not BMP-4 in the presence of DAF-4. Among the six mammalian type I receptors, mouse ActR-I (Ebner et al., 1993 ) TPR-I (Suzuki et al., 1994; Tomoda et al., 1994) ALK-3 (BMPR-I) (Koenig et al., 1994; Dewulf et al., 1995) and ALK-6 (BMPR-IB) (ten Dijke et al., 1994b) have already been reported. In the present paper, we report the cloning of the cDNA for mouse ActR-IB.
Several studies using murine embryonal carcinoma (EC) cells (Kondo et al., 1989; Hashimoto et al., 1990; Schubert et al., 1990; van den Eijnden-van Raaij et al., 1991) and in situ hybridization of activins and activin type II receptors (ActR-II and -1IB) in the postimplantation embryo (van den Eijnden-van Raaij et al., 1992; Manova et al., 1992; Albano et al., 1993; Feijen et al., 1994; Paulusma et al., 1994) suggest that this ligand-receptor system may have a regulatory function in differentiation and organogenesis.
In this paper, we have compared the global expression patterns of type I receptors for activin (ALK-2 or ActR-I, ALK-4 or ActR-IB) in midgestation mouse embryos. Documentation of the coincident expression of type I with type II receptors in particular will help to establish which cells in the mouse embryo at this stage of development are potentially sensitive to activin signaling, as argued previously for TGFPs (Roelen et al., 1994 Fig. 1 shows the deduced amino acid sequences of mouse ActR-IB cDNA obtained from a mouse placenta cDNA library. A comparison of the ActR-IB sequences from mouse, human (ten Dijke et al., 1993) and rat (He et al., 1993) revealed that ten amino acid residues were different between mouse and human, and only three amino acid residues were different between mouse and rat. In agreement with previous observations on this family of receptors (Massague et al., 1994 ) the amino acid sequences of the ectodomains are more divergent than the cytoplasmic domains.
We have also isolated the cDNA encoding the mouse homologue of ActR-I, of which the sequence was reported by Ebner et al. (1993) during our ongoing work as Tsk-7L. The amino acid sequence deduced from our cloned ActR-I sequence is identical to Tsk-7L, except for amino acid residue 60 in the ectodomain.
The mouse ActR-I and ActR-IB cDNAs were verified for their ability to bind activin A in the presence of a mouse type II activin receptor. For heterologous expression of receptors in mammalian cells we used a vaccinia virus (vv)-based system. For this, we constructed phage T7 promoter-based plasmids which can direct the expression of the inserted receptor cDNA. Infection with a recombinant vvT7 (see Section 4) completely suppresses the synthesis of host cell-specific proteins, and the vvT7 system results in high-level expression of T7 plasmid cDNA inserts in all cell types (including pig kidney PK(15) cells used here; Huylebroeck et al., 1994) . Chemical cross-linking using 1251-labeled activin A shows synthesis of the transfected type I receptors (of the expected molecular mass) with binding properties specific for activin. They bind the ligand in the presence of either one of the type II receptors ActR-II or ActR-IIB2 ( Fig. 2; shown are results obtained with ActR-IB (lanes 7-10); identical results were obtained with ActR-I (data not shown)). Binding of radiolabeled ligand is specific since it is efficiently competed with lo-fold excess cold activin. In agreement with previous observations (Mathews and Vale, 1991; Attisano et al., 1992) , the activin type II receptors bind ligand in the absence of type I receptors (Fig.  2 , lanes 3-4, ActR-II; 5-6, ActR-IIB2). The mouse type I receptors form a non-covalent complex with mouse type site is shown by a bold line. The amino acid sequence of human ActR-IB (ALK-4) has been reported by ten Dijke et al. (1993) . the rat homologue (R2) by He et al. (1993) . The nucleotide sequence of mouse ActR-IB has been deposited in the EMBL/GenBank library (accession number 231663).
II receptors.
This is illustrated by the co-immunoprecipitation of affinity-labeled type I receptor with a type II receptor, using the antiserum made against a purified ActR-II fusion polypeptide expressed in E. coli. This serum cross-reacts with ActR-IIB, but not with type I receptors (data not shown). The labeling intensity of the type II receptors decreases when they are co-expressed with the type I receptors. This has already been described and appears to be a non-specific effect (Attisano et al., 1993) .
Expression of mRNA for type I receptors
The expression of ActR-I and ActR-IB mRNA was first examined by Northern analysis of polyadenylated RNA from different tissues from the adult mouse. We used a DNA probe identical to the fragment from which anti-sense RNA was obtained for use in in situ hybridization. The ActR-I (Fig. 3A) and ActR-IB (Fig. 3C ) ectodomain probes do not cross-react. From this, and taking into consideration the high stringency conditions used for in situ hybridization, we expect that the corresponding anti-sense RNA probes exclusively detect receptor-specific transcripts in embryo sections. High level expression of the mouse ActR-I 3.5 kb mRNA was found in the heart, brain and lungs. Expression of the 4.4 kb ActR-IB mRNA was highest in brain, lung and skeletal muscle. Low level expression (given in order of decreasing levels) was found in liver, skeletal muscle, kidney and testis (ActR-I) and in kidney, heart, liver and testis (ActR-IB). Expression patterns and transcript sizes found in tissues from the adult mouse are similar to those in human (ten Dijke et al., 1993) and rat tissues (He et al., 1993) .
To our surprise, the ActR-I ectodomain probe detects an additional highly expressed 0.8 kb transcript in spleen (where its normal 3.5 kb transcript is not found), heart and lung (Fig. 3A) . The cytoplasmic tail-specific DNA probe does detect the 3.5 kb ActR-I transcript, but not the short transcript (Fig. 3B) . Therefore, the short transcript, if not an anti-sense RNA, may encode a truncated from of the ActR-I receptor. Fig. 2. Binding of recombinant activin A to type I/type 11 receptor combinations. The receptors were expressed from cDNA using a vaccinia virus T7-based expression system in PK(1.5) cells. The cells were affinity labeled using 1251-labeled activin. The crosslinked complexes were immunoprecipitated with the anti-A&R-II antiserum, which also crossreacts with ActR-IIB (the B2 isoform was expressed in this experiment). Shown are experiments involving A&R-IB, the conclusions with ActR-1 arc identical (data not shown). Samples were subjected to SDS-gel electrophoresis (8% polyacrylamide) after reduction, and analysis was by autoradiography.
10X activin, addition of ten-fold excess cold activin A; I, 11, affinity labeled type 1 and type 11 receptors, respectively.
Expression of ActR-I mRNAs during embryogenesis
Expression of the short transcript (0.8 kb) that hybridizes to the ActR-I ectodomain DNA probe was examined for different gestational stages by Northern analysis on polyadenylated RNA, using an ActR-I ectodomain antisense RNA probe. This short sense transcript is weakly expressed in the early postimplantation stages and the intensity of the signal increases as gestation proceeds (Fig. 3D ). By 15.5 days p.c., the 0.8 kb transcript is overexpressed compared with the 3.5 kb full size transcript (Fig. 3D ). This observation was confirmed by Northern analysis on total RNA isolated from embryos of different stages (data not shown). The transcript does not hybridize to an anti-sense oligonucleotide encompassing the transmembrane-encoding sequences (Fig. 3E) . Therefore, the possibility remains that this short transcript is translated into a soluble ActR-I receptor.
Distribution of type I activin receptor mRNAs in the 12.5-day p.c. mouse embryo 2.4.1. Localization of ActR-I mRNA.
In the 12.5-day p.c. embryo, ActR-I mRNA is expressed in various parts of the brain (Figs. 4A, B and 5, 6) . A hybridization signal is present in both cerebral hemispheres of the telencephalon (Fig. 6 ), the metencephalic rhombic lips and median sulcus ( Fig. 4A shows this in the pons/cerebellar junction) and medullary raphe (Fig. 4B) , the caudal part of the medulla oblongata (data not shown), the differentiating and enlarging hypothalamic and thalamic regions (Fig. 4A,B) , the neopallial cortex ( Fig. 4A ) and the infundibulum of the diencephalon that contributes to the formation of the pituitary (Fig. 4B ). Fig. 6 shows that the bottom of the mesencephalon is strongly positive for ActR-I mRNA, but in its roof, and in the floor of the rhombencephalon this mRNA is not detected.
The (posterior) semicircular canal in the vestibular component of the differentiating otocyst is negative, while the endolymphatic sac is positive (Fig. 4B ). This otocyst is known to develop in proximity to the vestibulocochlear (VIII) ganglion complex which is strongly positive for ActR-I mRNA (Fig. 4B ). The trigeminal ganglion, however, is only weakly positive. In the cranial vascular system, the carotid arteries and the middle cerebral artery, which forms from the internal carotid arteries, are positive (Fig. 4B ). The condensations of mesenchyma1 tissue that forms the outer table of the primitive ectomeninx are also positive (Fig. 4B ). Surface ectoderm also expresses ActR-I transcripts (Figs. 4A,B) . ActR-I mRNA detection using the ectodomain (A) and the cytoplasmic tail (B) specific probe; (C) ActR-IB mRNA detection using the ectodomain probe. Lanes: 1, heart; 2, brain; 3, spleen; 4, lung; 5, liver; 6, skeletal muscle; 7, kidney; 8, testis; (D) ActR-I mRNA detection in embryos using the ectodomain anti-sense RNA probe and (E) using the transmembrane anti-sense oligonucleotide probe. Lanes: 1, 7-day p.c.; 2, 1 l-day p.c.; 3, 13-day p.c.; 4, 15-day p.c.
Additional
transverse sections in the region of the pharynx, esophagus, stomatodeum and palate (data not shown) show that ActR-I mRNA is also present in the tongue mass, premusde mesodermal condensations and in precartilage primordium of the nasal septum and capsulae ( Fig. 4C ) and the primordium of the external ear. Arteries remain positive for ActR-I mRNA; these include the vertebral and the branchial arch artery and the palative artery region. The same sections also contribute to the finding that veins are negative for ActR-I mRNA; these include the primary head vein, the anterior cerebral vein, the ophthalmic vein and the anterior cardinal vein (data not shown). Precartilage primordium of Meckel's cartilage is negative, as well as the vomeronasal or Jacobson's organ, the upper and lower dental lamina, and nerves such as the spinal root of the accessory nerve and the nervus vagus (X).
In the facial region, the elevations associated with the formation of the follicles of the vibrissae contain ActR-I mRNA (Fig. 4C) .
Transverse sections in the thoracic region (Fig. 4D ) confirm that arteries are positive for ActR-I mRNA. These now include arteries around the heart (common part and separated parts of carotid artery, branchial arch arteries, the thoracic aorta (including its descending part; data not shown), the vitelline artery (the superior artery) in the mesentery of the midgut loop, and the paired umbilical arteries (data not shown). Veins (such as the marginal vein (data not shown), the anterior (Fig. 4D ) and the posterior cardinal vein (data not shown)), are negative for used: at, atrium; ba, branchial arch aorta; ca, carotid artery; cc, middle cerebral artery; ci, choroid invagination; co, neopallial cortex; cs, corpus striatum; cv, cardinal vein; dg, dorsal root ganglion; di, diencephalon; ec, surface ectoderm; en, endocardial cushion; es, endolymphatic sac; ht. hypothalamus; ip, infundibulum/(future) pituitary region; lb, limb; mc, mesenchymal condensations; mr, medullary raphe; mt, metencephalon; ne, neural tube; ns, nasal septum; nt, notochord; oe, esophagus; pp, precartilage primordium; rl, rhombic lip; SC, semicircular canal; su, median sulcus; ta, thoracic aorta; tg, trigeminal ganglion; th, thalamus; tl, tail; tr, trachea; tw, thoracic wall; uj, upper jaw; ve, ventricle; vi, vibrissa; IV, caudal part of fourth ventricle; VIII, vestibulocochlear ganglion complex.
ActR-I mRNA. The endocardial cushion tissue within the heart is also positive for ActR-I mRNA. Mesenchyme around precartilage condensations in the limbs is positive (Figs. 4D and 5) as well as mesenchyme in shoulder, snout and tongue (Figs. 5 and 6), intervertebral discs (Fig.  6B,D) , the rib primordia (Fig. 5) , sclerotomal condensations (data not shown), thoracic wall (Fig. 4D) , lung buds (but not the epithelium layer; Fig. 6B ), the septum transversum (data not shown), and the stomach, except for its epithelial lining (Figs. 5 and 6B, D) . The gonadal primordia weakly express ActR-I (Fig. 5) . The esophagus and trachea (Fig. 4C,D) are negative.
The ActR-I in situ hybridization studies were in fact done with the ActR-I ectodomain probe, which detects both the full-size ActR-I mRNA and the short transcript that may encode a soluble ActR-I receptor, but also with the kinase domain probe which exclusively detects the full-size ActR-I transcript. The global in situ hybridization patterns are comparable (a few examples are he. heart; ki, kidney (metanephros); Ii, liver; pm, pleuroperitoneal membrane; ri, rib primordium; st, stomach; IV, caudal part of fourth ventricle. analysis of ActR-I mRNA expression in sagittal sections of 12.5-day p.c. mouse embryos using the ActR-I-ectodomain (A,B) orendodomain probe (CD). Abbreviations used: di, diencephaion; he, heart; id, intervertebral disks; lu, lung buds; me, mesencephalon; np, nasal process; rh, rhombencephalon; st, stomach; te, telencephalon.
shown in Fig. 6 ), and therefore we consider ectodomainpositive signals as sites of full-size ActR-I receptor expression. 2.4.2. Localization of ActR-IB mRNA. ActR-IB mRNA is highly expressed in the central nervous system of the 12.5day embryo, both in the brain and the spinal cord (Figs. 7 and 8) . The cerebral hemispheres of the telencephalon are positive (Fig. 7H) and have a locally abundant expression which includes a sharp boundary of cells in the anteromedial part of the cortex (Fig. 7A) . The diencephalon and the basal plate of the metencephalon (Figs. 7A; including ponsitegmentum region, data not shown) are also strongly positive for ActR-IB mRNA. The choroid plexus, as well as the condensation of mesenchyme forming the outer table of the primitive ectomeninx (Fig.  7A) , are negative for ActRI-B mRNA. Additional transversal sections of the cranial region (data not shown) show expression in both the hypothalamus and thalamus parts of the diencephalon, but precartilage primordium of the petrous part of the temporal bone, the rostra1 extremity of the endolymphatic sac and the trigeminal nerve (V) from the basal region of the pons are negative. However, several cranial ganglia are positive; the vestibulo-cochlear (VIII) ganglion, the superior ganglion of vagus (X)-XI ganglion complex and the trigeminal ganglion (V) (Fig.  7B) . Also the facial nerve (VII) contains ActR-IB mRNA (Fig. 7B) .
The marginal and mantle layers of the spinal cord are positive (Fig. 7B-H) , as are the intervertebral discs (Fig.  7H) .
The inner layer of the double-walled optic cup in the developing eye, named at this stage the inner nuclear (neuroblastic) layer, is also positive (Figs. 7B and 8B ). It cannot be established whether those ActRI-B-positive cells will later differentiate into the light-receptive elements (the rods and cones) or to neurons and supporting cells. The strong signal in the pigment layer of the retina is a false positive signal, since negative controls using sense RNA probes or unrelated probes give the same signal (data not shown). Other transversal sections (data not shown) show further ActRI-B mRNA expression in the body wall (see also Figs. 7 and 8), the fourth ventricle in the brain, the dorsal component of the first branchial pouch, the neopallial cortex in the region of the future olfactory lobe, and the inferior ganglion of the glossopharyngeal (IX) nerve. Also the epithelial lining of the urethral lumen is positive for this mRNA (Fig. 7G) .
Further the presence of ActR-IB transcripts is detected in the body wall (Figs. 7C and 8A,B) , the dorsal root ganglia (Figs. 7C-G and 8A,B) , the olfactory epithelium ( Figs. 7C and 8A ; negative for ActR-I mRNA), Jacobson's organ (Fig. 7C) , the tooth primordium (upper and lower dental lamina) (Fig. 7C) , the pharyngeal region of the foregut (Fig. 7C) , and the submandibular gland (Fig.  7C) . In further transversal sections in the direction of the thorax, additional expression sites are visible in the esophagus ( Fig. 7D,E ; ActR-I is not expressed in the esophagus) and the cervico-thoracic sympathetic ganglion (Fig. 7D,E) , the epithelial lining of the lungs (negative for ActR-I mRNA) (Fig. 7F) , the epithelial lining of the stomach (Figs. 7F and 8B ; negative for ActR-I mRNA), the midgut and hindgut (Figs. 7F, G and 8B) and in the gonadal and pancreatic primordia (Figs. 7G and 8B ). The paramesonephric duct is negative for ActR-IB mRNA, as well as the precartilage primordium of the lumbar vertebral body (Fig. 7G) . The elevations associated with the formation of the follicles of the vibrissae in the facial region also contain ActR-IB mRNA (Figs. 7D and 8B ).
Discussion
In this paper, we report the isolation of the murine homologue of human ActR-IB (also named ALK-4) cDNA. Of the ten differences in amino acid residues between mouse and human ActR-IB, eight were located in the ectodomain of the type I receptor. The sequence is thus well conserved between species.
Affinity cross-linking with activin A shows this ActR-IB receptor binds activin in the presence of a type II activin receptor with which it is shown to form a noncovalent complex. Identical results were obtained with mouse ActR-I. The results from these experiments involving all murine homologues of the known activin type I bp, basal plate of metencephalon; bw, body wall; cp, choroid plexus; ct. cervico-thoracic sympathetic ganglion; dg, dorsal root ganglion; di, diencephalon; dl, dental lamina (tooth primordium); du, duodenum; ec, surface ectoderm; ey, eye; fn, facial nerve; go. gonad primordium; he, heart; id, intervertebral disks; ja, vomeronasal organ (Jacobson's organ); Ib, limb; li, liver; lu, lung; me, mesencephalon; mi, midgut; mp, mandibular process; mt, metencephalon; ne, neural tube; nl, inner nuclear layer of the eye; oe, esophagus; 01, olfactory epithelium; pc, precartilage condensation; ph, pharyngeal region of the foregut; pi, primordium of pinna; rc, anteromedial part of the cortex; SC, spinal cord; sg, submandibular gland; st. stomach; te, telencephalon; tg, trigeminal ganglion; d, tail; to, tongue; tr, trachea; tu, genital tubercle; tw, thoracic wall; uj, upper jaw; ul, urethral lumen; ur, blood vessels of the umbilical region (Fig. 6F ). urogenital ridge (Fig. 6G) ; vc, vestibulocochlear ganglion complex; ve. ventricle of the heart; vi, vibrissa; IV, fourth ventricle; IX, inferior gangIion of glossopharyngeal nerve; X-XI, superior ganglion of vagus (X)-cranial accessory (XI) ganglion complex. and type II receptors thus agree with observations made by others (Attisano et al., 1993; Tsuchida et al., 1993; Carcamo et al., 1994; ten Dijke et al., 1994b) . In the presence of a type II activin receptor, the human ActR-IB homologue is essential for the signaling of a strong growth-inhibitory response in susceptible cells (Carcamo et al., 1994) , and A&R-I and ActR-IB stimulate transcription from a reporter gene containing regulatory elements of the PAI-promoter (Attisano et al., 1993; Carcamo et al., 1994) . These type I receptors may thus serve to mediate different biological effects of activins, including those in the postimplantation mouse embryo. We then used cDNA probes derived from both type I receptors for activin to analyze the expression of these genes in different tissues from the adult mouse by Northern blotting. This was found to be nearly ubiquitous for ActR-I and ActR-IB. A surprising finding was the expression in adult heart, lung and spleen of an additional 0.8 kb-long ActR-I transcript. This sense transcript is also expressed during embryonic development, where it becomes more abundant as gestation proceeds. At this stage of our work, it cannot be excluded that this transcript encodes a soluble type I receptor. This has not yet been documented within the emerging superfamily of receptors for ligands of the TGF-/3 superfamily. Attisano et al. (1993) also detected an additional shorter ActR-I transcript in human placenta. The possible role of such a soluble type I activin receptor is not yet clear. It could interfere with signaling by binding to activin that is already complexed with type II receptors. Fig. 8 . ActR-IB mRNA expression in frontal sections of 12.5day p.c, embryos. Abbreviations: bc, buccal cavity; br, brain; bw, body wall; dg, dorsal ganglion; ec, surface ectoderm; ey, eye; gt, gut; lb, limb; li, liver; nl, inner nuclear layer of the eye; 01, olfactory epithelium; pa, pancreatic primordium; SC, spinal cord; St, stomach; vi, vibrissa.
A number of both experimental and descriptive studies in the amphibian and murine embryo largely rule out a direct role of activins as major endogenous inducers of mesoderm formation in the vertebrate embryo (Feijen et al., 1994; Schrewe et al., 1994; Schulte-Merker et al., 1994; Slack, 1994; Vassali et al., 1994; Matzuk et al., 1995a,b) . This however does not exclude the possibility that certain activin receptors may be involved in this early process (Hemmati-Brivanlou and Melton, 1992) but these may be a component of a TGF-/?-like ligand (other than activin) dependent signaling receptor complex (SchulteMerker et al., 1994) . ActR-IIB has been shown to be strongly expressed in the early postimplantation mouse embryo (Feijen et al., 1994) . As yet, no homozygous ActR-IIB knock-outs are available in the mouse. Our preliminary in situ hybridization data on the expression of ActR-I and -1B mRNA in 6.59.5day p.c. embryos (data not shown), suggest a broad and very weak expression of the type I receptor transcripts. For these reasons, we have extensively documented activin type I receptor expression primordially in midgestation embryos.
In 12.5day p.c. embryos, both ActR-I and ActR-IB are predominantly expressed in the different parts of the brain. In the telencephalon, both type I receptors are coexpressed with ActR-IIB (Feijen et al., 1994) . The situation appears to be different in embryonic rat brain, where the mRNAs of both type II activin receptors have been found throughout the brain (and spinal cord and dorsal root ganglion; Roberts, 1994) . In other parts of the brain, such as the diencephalon, all combinations of transcripts encoding type I and type II receptors are found. In both species, the Pa mRNA is the only inhibin chain mRNA expressed in the brain at midgestation and later stages (Feijen et al., 1994; Roberts and Barth, 1994) .
The possible existence of another type I receptor for activin besides ActR-I in the developing brain has been put forward previously, on the basis of only partially overlapping expression sites of ActR-I with the type II receptors near B-chain mRNA expression sites (Feijen et al., 1994) . Our data now demonstrate ActR-IB to be this or one such additional receptor. These data also support earlier suggestions, made from experiments with transfected receptors and reporter genes in tissue culture cells, that ActR-I and ActR-IB are the prime candidate type I receptors for mediating activin bio-activities in vivo (Carcamo et al., 1994; ten Dijke et al., 1994b) , but it cannot be excluded that these receptors also bind other ligands of the TGF-/3 superfamily in vivo. In particular, it has been shown that ActR-I can bind TGF-p (Ebner et al., 1993) , activin (Attisano et al., 1993; ten Dijke et al., 1994b) and OP-1 (BMP-7) (ten Dijke et al., 1994~; Yamashita et al., 1995) and only a limited number of ligands have thus far been tested for binding to ActR-I-or ActR-IB-containing receptor complexes.
More than one type I/type II receptor combination might also be used in the spinal cord of the 12.5-day mouse embryo, which has been shown to express activin B subunit mRNA abundantly in its ependymal layer, while the mantle layer and marginal layer are negative (Feijen et al., 1994) . ActR-I mRNA is restricted to the ependymal layer of the spinal cord, while ActR-II is not expressed there, although ActR-IIB mRNA is (Feijen et al., 1994) . ActR-IB mRNA, strongly expressed throughout the different layers of the spinal cord, may also interact with ActR-II in the mantle layer. ActR-II and -1IB transcripts are also coincidentally expressed in the spinal cord of the 13-20-day p.c. rat embryo, but no P-chain mRNA is detected in the spinal cord (Roberts and Barth, 1994) . Together with the presence of either one or both type I receptor mRNAs in several (but not all) ganglia, our observations at this stage suggested that activin B might regulate neuronal cell growth, differentiation and/or survival of some type of nerve cells, as proposed previously (Schubert et al., 1990; Schubert and Kimura, 1991; van den Eijnden-van Raaij et al., 1991) . However, homozygous mice carrying null mutations in activin A and/or activin B or Act-RI1 do not show any obvious defects in neural development (Schrewe et al., 1994; Vassali et al., 1994; Matzuk et al., 1995a,b) .
Both type I receptor mRNAs are also expressed in the elevations that are associated with the formation of the follicles of the vibrissae in the facial region. In the mouse embryo, developing whisker follicles have been shown to express exclusively ActR-II (restricted to epithelium), not ActR-IIB mRNA, and the PA-chain mRNA (restricted to mesenchyme) (Feijen et al., 1994) . In the rat embryo, the type II receptors have not been detected in the vibrissae, but PA-chain mRNA was found in the dermal papilla and the surrounding connective tissue (Roberts, 1994) . Thus, activin A could possibly play a role in the differentiation to mature follicles (Feijen et al., 1994) and act in the mouse embryo through both type I receptors and ActR-II. However, the recent data on the homozygous knock-out of ActR-II in the mouse suggest that in the developing whiskers, both type I receptors may signal through receptor complexes containing type II receptors other than ActR-II (Matzuk et al., 1995a) .
A unique receptor combination of ActR-IB (see Figs. 9B and 10B) and ActR-IIB (Feijen et al., 1994 ) is detected in the inner nuclear neuroblastic layer of the developing aye of the mouse embryo. ActR-IIB mRNA is also localized in the nuclear layer of the retina from 12-20-day p.c. rat embryos (Roberts, 1994; Roberts and Barth, 1994) . #L?* mRNA has been detected in the condensed mesenchyme in the orbita around the developing eye, while Pa mRNA is found in the eye tarsus. Interestingly, activin A has been purified from the conditioned medium from a chemically induced eye tumor cell clone (Schubert et al., 1990) . This activin A promotes the survival of loday rat embryonic neural retina cells (Schubert et al., 1990) . ActR-II and /3a homozygous null mice are born with eye defects, but the observed so-called 'open eye' phenotype (at birth) appears to be not completely penetrant and may be influenced by the genetic background of the mouse strain (Schrewe et al., 1994; Vassalli et al., 1994; Matzuk et al., 1995a) .
Mesenchyme, developing muscles, and precartilage primordium of the tongue, snout, ribs and shoulders represent other expression sites of the two type I receptor genes during development. Slightly different, but partially overlapping type I/type II receptor combinations are possible within these internal organs in which the PA subunit mRNA is generally not expressed in the epithelium, but is predominantly expressed in mesenchymal regions of these organs (Feijen et al., 1994; Roberts and Barth, 1994) . ActR-IIB mRNA is present in the epithelial cells of various fetal rat tissues (snout, tongue, stomach and lung). Only ActR-IB, not ActR-I mRNA, is detected in the epithelial cells of the lungs. The weak signals observed previously in the stomach for ActR-II and -1IB in the mouse embryo in both the epithelial and mesenchymal layers (Feijen et al., 1994) (in the rat embryo, only ActR-IIB is reported in the epithelial layer of the stomach; Roberts, 1994) , is complemented by ActR-IB in the epithelial layer only, while no expression of ActR-I is detected. Peripheral structures in the metanephros express only ActR-IIB (Feijen et al., 1994) and this exclusively in combination with ActR-I mRNA. The gonadal primordia weakly express both ActR-I and ActR-IB. Activin B is expressed in these developing organs, while a possible sex-related expression has been observed for both ActR-IIB and activin A (Feijen et al., 1994) .
The semicircular canals of the otocyst, whilst positive for both type II receptor mRNAs in its epithelium (Feijen et al., 1994) , are negative for both of the type I receptors for activin. In general, such observations may indicate yet other ligand/type I receptor complexes to share a type II activin receptor in the mouse embryo.
In conclusion, the combination of published data on the expression of the PA and /3n chain of inhibins and the type II receptors for activins in the mouse (Feijen et al., 1994) and the rat embryo (Roberts, 1994; Roberts and Barth, 1994) with the data on the two known signaling activin type I receptors (this study), indicate activins (if no other ligands bind to the activin receptors) may have different functions during the period of organogenesis through signaling of the high-affinity heteromeric type I/type II receptor complexes. This may hold for the developing brain, the spinal cord, pituitary, whisker follicles, the eyes, parts of the respiratory and digestive tracts, and be important in the morphogenesis of craniofacial and certain thoracic structures (Table 1 ). In addition, patterns of ligand, type I and type II receptor expression in the embryo may be grossly similar to those in the juvenile and/or adult rat and mouse, indicating that the cell specific expression of the genes may be established early in development (Cameron et al., 1994; Roberts, 1994 ). An exception to this forms the pituitary, that in the embryo expresses ActR-IIB and ActR-I (Feijen et al., 1994; Roberts and Barth, 1994) , while cross-linking studies on cells from the adult pituitary show expression of ActR-II and ActR-IB (Yamashita et al., 1995) . It is worth noting that in or adjacent to some of the discussed developing structures mRNA for follistatin, in fact coding for different isoforms of activin-binding proteins (which inhibit its activity), is also present (Feijen et al., 1994) .
Our data on the distribution of ActR-I transcripts will contribute to studying the significance in vivo of the other finding that OP-1 may signal through ActR-I/ActR-II and type I BMP /ActR-II receptor complexes (ten Dijke et al., 
II-A/B -(II-B in metanephros)
Expression of type II receptors and activins are compiled from in situ hybridization data in the mouse (Feijen et al., 1994) and in the rat (Roberts and Barth, 1994) . +/-, weak expression; ', possible sex related differences in expression, epi., epithelial expression; mes., mesenchymal expression; precart., expression in precartilage mesenchymal condensations; ( ), reported in rat only.
1994~; Yamashita et al., 1995) . The spatio-temporal expression patterns of both type I receptors for BMPs in the mouse embryo have been determined recently (Dewulf et al., 1995) . It is possible that the composition of signaling receptor complexes in vivo is very complex and it cannot be excluded that in the developing embryo, ActR-I, but also ActR-IB, may bind ligands other than activin, in combination with either the known activin type II receptors, or, other hitherto unidentified type II receptors. Our ActR-I and ActR-IB in situ data presented here will significantly contribute to further studies on the role of these receptor complexes in postimplantation development.
Experimental procedures

Reagents
The open reading frame of ActR-II (nucleotides 67-1620; Mathews and Vale, 1990) was amplified by reverse transcriptase-PCR from AtT-20 cells (data not shown) and cloned into pCRlOO0 (Invitrogen).
The ActR-II sequences were still flanked by a GC-rich stretch of nucleotides derived from pCR1000. Prior to further cloning in pTZ18/19R (Mead et al., 1986) , we carried out a one-step mutagenesis (Bio-Rad) to create an EcoRI site closer to the ATG translation initiation codon and change the sequence into a Kozak consensus sequence (Kozak, 1989) (data not shown). This ActR-II insert was used for expression. ActR-IIB (isoform B,; Attisano et al., 1992) was modified similarly to ActR-II (data not shown).
Activin A was a gift from Innogenetics S.A. Its production in insect cells, and its large-scale purification from the medium of recombinant Baculovirus-infected cells have been summarized elsewhere .
A polyclonal antiserum was produced that was directed against the cytoplasmic domain of mouse ActR-II. The DNA fragment encompassing the coding sequence for the cytoplasmic tail of ActR-II (the first 25 juxtamembrane residues were missing from the final construct) was cloned into the E. coli expression vector pEmTNFMPH, which allows temperature-inducible production of a 42 kDa mouse tumor necrosis factor (TNF) fusion protein which can be schematically represented as follows: mTNFt_25-(His),s-ActRII.
Western analysis using an anti-mTNF antiserum detects intact fusion protein, together with two discrete anti-mTNF-reactive smaller polypeptides (30 and 35 kDa), representing degradation products. The fusion proteins form inclusion bodies. Cellular proteins of induced E. coli were obtained in 7 M GuHCl and, after clearing by centrifugation, loaded on an IDA-Ni column prepared with Chelating Sepharose 6B (Pharmacia). (His)e-containing polypeptides were eluted with 100 mM imidazole. SDS-polyacrylamide gel electrophoresis (reducing conditions) followed by protein staining or by Western analysis demonstrated successful co-purification of the intact fusion protein and the two smaller polypeptides.
Purified fusion protein (in 7 M GuHCl) was dialyzed against 6 M urea and prepared for immunization of rabbits. The AZAP II mouse placenta cDNA library was a gift from Dr. Hideo Toyoshima; other mouse cDNA libraries and the RNA blots from mouse were obtained from Clontech.
Cloning of mouse ActR-I and ActR-IB cDNAs
The LZAP II mouse placenta cDNA library of 2 X lo6 independent clones was screened with the human ActR-IB cDNA probe (SacI-EcoRI fragment; nucleotides 1178-1967; ten Dijke et al., 1993) labeled by the Megaprime labeling system (Amersham). Hybridization to nitrocellulose replica filters was carried out as described (Sambrook et al., 1989) . The filters were washed twice with 2x SSC (1 x SSC is 15 mM sodium citrate-150 mM NaCl) and 0.1% SDS at 37°C for 15 min, and twice with 0.5 x SSC-O. 1% SDS at 55°C for 15 min. Bacteriophages were purified as described (Sambrook et al., 1989) . Nine positive clones were obtained by screening with the human ActRI-B probe, and the longest insert (2.2 kb) was isolated and sequenced.
Two mouse embryo (11.5-and 15.5-day p.c.) cDNA libraries and one fibroblast cDNA library (about 80 000 and 400 000 phages each, respectively) were hybridized under stringent conditions using ligand-binding domain (EcoRI-AvaI fragment; nucleotides -104 to +579) and kinase domain (AvaI-PstI fragment; nucleotides 579-1861) specific cDNA fragments of human A&R-I (also named ALK-2; ten Dijke et al., 1993) , respectively, as probe. Four positive recombinant phages were isolated: one from the 11.5-day embryo library (using a probe corresponding to the kinase domain), one from the 15.5-day embryo library (probe corresponding to the ligandbinding domain), and two from a fibroblast library (one hybridizing with the ligand-binding domain probe, one with the kinase domain probe). The cDNA inserts varied in length (from 93 bp to 838 bp) and overlapped partially, and could be lined-up with the human ActR-I sequence (ten Dijke et al., 1993) . A 123-bp long fragment (nucleotides 1041-l 164) that was missing from the assembled sequence was obtained by PCR amplification of a 330-bp fragment from the fibroblast cDNA library. The deduced complete amino acid sequence of the murine homologue of human ActR-I (Attisano et al., 1993 ) turned out to be identical to Tsk-7L (Ebner et al., 1993) except for residue 60 (Tyr (codon UAC) in Tsk-7L, Asn (codon AAC) in ActR-I). This ectodomain residue in the mouse ActR-I sequence is identical to the residue in human ActR-I (ALK-2; ten Dijke et al., 1993) .
Both strands of the cDNAs were sequenced using the dideoxy chain-termination method (Sanger et al., 1977) using Sequenase (U.S. Biochemical Corporation (U.S.B.)) and specific oligonucleotide primers. Compressions were resolved using 7-deaza-GTP (U.S.B.). DNA sequences were analyzed by using the DNA STAR computer program (DNA STAR, Ltd.). Amino acid sequences were compared by the Clustal V alignment program (Higgins et al., 1991) with some manual adjustment.
Northern hybridization
The following plasmids were used to generate cDNA probes for Northern analysis (the same plasmids and inserts were used to prepare RNA probes for in situ hybridization): the pTZ18/19R (Mead et al., 1986 ) and pGEM-3Z (Promega) derivatives pTZALK-2 and pIS-ALK-2 containing a +470-bp long EcoRI-XmnI ectodomain fragment from ActR-I, and the pGEM-3Z derivative pNHALK-2 containing the +990-bp long KpnI-Sac1 cytoplasmic tail fragment from ActR-I; the pGEM-3Z derivative pISALKcontaining the 339-bp long NaeI fragment from ActR-IB. The transmembrane anti-sense oligonucleotide probe (Fig. 3E ) is 36 nt long (amino acid residues 132-143; Ebner et al., 1993) .
Northern analysis on polyadenylated RNA was carried out as described (ten Dijke et al., 1993) using mouse multiple tissue blots (Clontech; 2pg poly(A)-RNA was loaded per lane). For autoradiography, a phosphor-imager (Molecular Dynamics) was used.
Heterologous expression of type I receptor cDNAs
Phage T7 promoter plasmid-based expression of receptors in mammalian cells pre-infected with a recombinant vaccinia virus expressing T7 RNA polymerase (vvT7; Fuerst et al., 1986) was carried out as follows: subconfluent cells were washed with phosphate-buffered saline and infected with vvT7 (multiplicity of infection 5-10) for 1 h at 24°C. Subsequently, growth medium was removed and appropriate combinations of T7 promoter-based plasmids with receptor cDNA insertion were transferred into the cells by lipofection using DOTAP (Boehringer) for 16 h at 37'C.
Afinity crosslinking and immunoprecipitation
Activin A was iodinated by chloramine T oxidation to a specific activity of 70-140&i&g, according to the procedure of Frolik et al. (1984) , with some minor modifications.
Affinity crosslinking was carried out as described by Franzen et al. (1993) with some modifications.
Briefly, recombinant receptor-expressing cells (in 28 cm* dishes) were washed with binding medium (Dulbecco's MEM containing 20 mM Hepes (pH 7.5) and 0.2% bovine serum albumin) for 10 min at 4°C. Following binding, the cells were washed gently three times with Hepes-buffered saline (HBS) and subsequently incubated in 3 ml HBS-1 mM BS3 (bis-sulfosuccinidylsuberate, Pierce Chemical Company) for 30 min at 4°C. The reaction was subsequently quenched for 5 min at 4°C with 150~1 10 mM Tris (pH 7.5), 2 mM EDTA and 200 mM glycine. Cells were scraped off the dishes in 1 ml detachment buffer (10 mM Tris, pH 7.4, 1 mM EDTA, 10% glycerol, 0.3 mM phenylmethylsulfonylfluoride (PMSF)) and collected by centrifugation.
Cells were then solubilized in lOO@ 10 mM Tris (pH 7.4), 1 mM EDTA, 125 mM NaCl, 1% Triton X-100, 0.3 mM PMSF, 100 kIU aprotinin/ml and kept at 0°C for 20-30 min. Lysates were then cleared by centrifugation.
Fifty microliters of lysate were diluted with 1 ml of RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% deoxycholate, 0.1% SDS and 0.3 mM PMSF). The extracts were precleared with a suspension of protein A Sepharose beads (Pharmacia) for 1 h at 24°C. The extracts were incubated for 16 h at 4°C with anti-ActR-II antiserum, followed by an incubation for 1 h at 24°C with beads. These were collected by centrifugation, washed gently for four times in RIPA buffer and once in 10 mM Tris (pH 8) and 150 mM NaCl. The proteins were then solubilized in Laemmli sample buffer containing 4% 2-mercaptoethanol and analyzed by SDSpolyacrylamide gel electrophoresis.
Embryos
Mouse embryos were collected between 12.5-and 13-day post-coitum (p.c.) and obtained from Fi crosses between C57BL/6J (females) X CBA (males). Noon on the day of finding a vaginal plug was designated day 0.5.
In situ hybridization
Constructs with receptor ectodomain inserts that showed specificity in Northern analysis of adult mouse tissues were used for in situ hybridization.
After linearization of the plasmid downstream of the inserted DNA fragment, anti-sense or sense (used as negative control; data not shown) SP6 or T7 RNA polymerase-dependent transcripts were obtained as required for the following mouse receptor ectodomain-coding fragments: ActR-I, a 470-bp long fragment, spanning ectodomain amino acid residues 1-113 (Ebner et al., 1993) , and ActR-IB, a 339-bp long fragment, spanning amino acid residues 80-132 (this paper). An ActR-I-containing 1034-bp long subcloned fragment (encompassing amino acid residues 166-509; Ebner et al., 1993) was used to obtain endodomain-specific anti-sense RNA probe (Fig. 6C,D) .
Radiolabeled (a-[35S]-UTP; Amersham) RNA probes were prepared by in vitro transcription using T7 or SP6 RNA polymerase. The RNA probes were then subjected to limited alkaline treatment, such that an average length of 350 nucleotides was obtained, as estimated by denaturing agarose gel electrophoresis (Sambrook et al., 1989) .
In situ hybridization was carried out according to Wilkinson and Green (1990) with minor modifications. Ilford K5 photo emulsion 1: 1 diluted with 2% glycerol (in water) was used for autoradiography.
After drying the sections, they were exposed at 4°C for 2-3 weeks in a light-safe box containing silica gel. Kodak D19 developer was used, and sections were then fixed in Kodak UNIFIX and counterstained with hematoxylin.
Photography was under a Zeiss Axiophot microscope equipped with bright field and dark field illumination, and Plan-Neofluar 1.25 X/O.035 and 2.5 x/O.075 objectives.
